CLINICAL_TRIALS
ClinicalTrials.gov record update
Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Lymphocytes Transduced by RV-SFG.CD19.CD28.4-1BBzeta Retroviral Vector - a Unicenter Phase I/II Clinical Trial
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03676504
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:26:20.960102+00:00
- Published At
- 2024-07-29T00:00:00+00:00
- Record Updated At
- 2024-07-29
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Acute Lymphoblastic Leukemia, Adult", "Acute Lymphoblastic Leukemia, Pediatric", "Chronic Lymphocytic Leukemia", "Diffuse Large B Cell Lymphoma", "Follicular Lymphoma", "Mantle Cell Lymphoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-07-29"- protocolSection.identificationModule.nctId
"NCT03676504"- protocolSection.identificationModule.officialTitle
"Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Lymphocytes Transduced by RV-SFG.CD19.CD28.4-1BBzeta Retroviral Vector - a Unicenter Phase I/II Clinical Trial"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE1", "PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.